Calcium and vitamin D supplements have long been widely recommended for bone health, especially for older adults at risk of fractures and falls. However, a major updated systematic review and meta-analysis published in the BMJ in 2026 challenges this long-standing assumption.
This article provides a summary of the findings, and intended for healthcare professionals, researchers, and evidence-based practitioners interested in musculoskeletal health, osteoporosis prevention strategies, and nutritional supplementation guidelines.
The study titled “Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis” evaluated whether these supplements reduce fracture and fall risk in adults.
Calcium supplementation alone was evaluated across multiple trials involving thousands of participants.
The review concluded that calcium supplements likely provide little to no protective benefit against fractures in generally healthy older adults living in the community.
Although small statistical variations were observed in some outcomes, these did not meet thresholds considered clinically meaningful.
Vitamin D monotherapy was the most extensively studied intervention in the review.
The certainty of evidence was high, indicating strong confidence that vitamin D alone does not reduce fractures or falls in the studied populations.
This finding is particularly important given the widespread global use of vitamin D supplementation for bone protection.
Combination therapy was also evaluated across more than 50,000 participants.
While a few results reached statistical significance, the absolute benefit was minimal and not considered clinically relevant for most populations.
Overall, combined supplementation showed little to no meaningful effect on fracture or fall prevention.
The researchers performed extensive subgroup analyses, including:
No consistent subgroup showed meaningful benefit from supplementation.
Sensitivity analyses confirmed that results remained stable even when adjusting for bias, study size, and methodological differences.
This BMJ meta-analysis provides one of the most comprehensive evaluations of calcium and vitamin D supplementation to date.
Despite widespread use, especially among older adults, the evidence does not support supplementation as a primary fracture prevention strategy in the general population.
The study also highlights significant global healthcare costs associated with routine supplementation.
Healthcare systems may need to reassess prescribing practices and guideline recommendations in light of this evidence.
Although generally considered safe, calcium and vitamin D supplementation is not risk-free.
Reported concerns include:
Even small risks may be relevant when benefits are minimal or absent.
This evidence suggests a shift in clinical thinking is needed.
Rather than relying on routine calcium or vitamin D supplementation for fracture prevention, clinicians may consider:
Supplementation may still be appropriate for individuals with confirmed deficiency or specific medical conditions, but not as a universal preventive measure.
The BMJ 2026 systematic review provides strong evidence that calcium, vitamin D, and combined supplementation offer little to no meaningful benefit in preventing fractures or falls in most adults.
While small statistical effects were observed in certain analyses, these did not translate into clinically important outcomes.
Overall, the findings challenge long-standing public health recommendations and suggest that routine supplementation for fracture prevention should be reconsidered in evidence-based clinical practice.
Massé O, Mercurio CM, Dupuis S, et al. Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis. BMJ 2026;393:e088050. Published 20 May 2026.
This article is an educational summary based on publicly available research. It is intended for informational purposes only and is not medical advice. It should not be used to diagnose, treat, or replace professional clinical judgment. Healthcare professionals should consult the full original publication and relevant clinical guidelines before making treatment decisions.

Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.